Quanterix Co. (NASDAQ:QTRX) Shares Purchased by abrdn plc

abrdn plc raised its holdings in shares of Quanterix Co. (NASDAQ:QTRX) by 24.4% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 206,923 shares of the company’s stock after acquiring an additional 40,525 shares during the quarter. abrdn plc’s holdings in Quanterix were worth $2,200,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of QTRX. nVerses Capital LLC acquired a new position in shares of Quanterix during the 3rd quarter valued at $60,000. Peapack Gladstone Financial Corp purchased a new position in Quanterix in the third quarter valued at about $131,000. SG Americas Securities LLC acquired a new position in shares of Quanterix during the third quarter worth about $139,000. Tallon Kerry Patrick purchased a new stake in shares of Quanterix in the fourth quarter worth about $169,000. Finally, Intech Investment Management LLC acquired a new stake in shares of Quanterix in the third quarter valued at about $170,000. 86.48% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, TD Cowen increased their price objective on shares of Quanterix from $13.50 to $16.00 and gave the company a “hold” rating in a research report on Wednesday, November 13th.

Quanterix Trading Down 3.6 %

Shares of NASDAQ:QTRX opened at $7.83 on Tuesday. The firm’s 50 day moving average is $10.28 and its two-hundred day moving average is $11.94. The firm has a market capitalization of $301.64 million, a P/E ratio of -7.39 and a beta of 1.33. Quanterix Co. has a 52 week low of $7.72 and a 52 week high of $29.70.

Quanterix (NASDAQ:QTRX) last released its earnings results on Monday, December 23rd. The company reported ($0.22) EPS for the quarter. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. Analysts predict that Quanterix Co. will post -0.98 EPS for the current year.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.